Unique ID issued by UMIN | UMIN000026968 |
---|---|
Receipt number | R000030922 |
Scientific Title | A prospective multicenter registry on outcomes of endovascular treatment in patients with atherosclerotic femoropopliteal artery disease in Japan |
Date of disclosure of the study information | 2017/04/12 |
Last modified on | 2021/10/18 15:07:39 |
A prospective multicenter registry on outcomes of endovascular treatment in patients with atherosclerotic femoropopliteal artery disease in Japan
Guide SFA
A prospective multicenter registry on outcomes of endovascular treatment in patients with atherosclerotic femoropopliteal artery disease in Japan
Guide SFA
Japan |
Patients with symptomatic PAD with lesions in femoropopliteal artery who have elected to receive endovascular treatment.
Cardiology | Vascular surgery |
Others
NO
This registry is designed as a prospective, multicenter, observational study for Japanese patients with symptomatic peripheral artery disease (PAD) caused by lesions in superficial femoral artery and/or proximal popliteal artery (PPA). The objective of the study is to establish the safety and effectiveness of endovascular treatment (EVT) in the real world under current medical environment in Japan, and to obtain fundamental data such as usage of medical devices and medications for further improvement of PAD treatment. In the study, EVT will be performed using any SFA/PPA devices marketed in Japan.
Safety,Efficacy
Not applicable
Freedom from Target Vessel Revascularization (TVR)in the index limb at 1 and 2 year(s)
Improvement of walking ability measured by means of WIQ or a medical interview, MAE within 30days after index procedure, EVT procedure related adverse events
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Informed consent to being a subject of this study and agreeing to undergo follow-up examinations at 30 days, and 1 and 2 years after receiving EVT.
1) Planned bypass surgery or major amputation within 30 days after EVT, 2) Life expectancy of less than two years, 3) Acute limb ischemia (ALI), 4) Anti-thrombotic treatment is not applicable.
3500
1st name | Masato |
Middle name | |
Last name | Nakamura |
Toho University Ohashi Medical Center
Cardiovascular internal medicine
153-8515
2-17-6 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan
0334681251
masato@oha.toho-u.ac.jp
1st name | Kaori |
Middle name | |
Last name | Shimogama |
Japan Endovascular Treatment Conference
Office of Guide SFA Registry
814-0001
7F, Fukuoka International College of Health and Welfare, 3-6-40, Momochihama, Sawara-ku, Fukuoka-shi
03-3468-1251
guide-sfa.registry@j-et.jp
Japan Endovascular Treatment Conference
Office of Guide SFA Registry
Boston Scientific
Profit organization
Toho University, Oahshi Medical Center
2-22-36 Ohashi Meguroku Tokyo 153-8515 Japan
0334681251
masato@oha.toho-u.ac.jp
NO
2017 | Year | 04 | Month | 12 | Day |
Unpublished
1003
No longer recruiting
2017 | Year | 01 | Month | 10 | Day |
2017 | Year | 02 | Month | 21 | Day |
2017 | Year | 04 | Month | 13 | Day |
2023 | Year | 06 | Month | 13 | Day |
2023 | Year | 12 | Month | 31 | Day |
Prospective registry
2017 | Year | 04 | Month | 12 | Day |
2021 | Year | 10 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030922
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |